Recalled batches of products manufactured by PHARMATHEN INTERNATIONAL
2026-01-07Product Description :
|
الاسم التجاري |
الاسم العلمي |
رقم التسجيل |
رقم التشغيلة المتأثرة |
الشركة الصانعة |
|
Trade Name |
Scientific Name |
Register Number |
Affected batch number |
Manufacturer |
|
Ryxidal 25 mg |
RISPERIDONE |
2103233397 |
4400435, 4400888, |
PHARMATHEN INTERNATIONAL |
|
Ryxidal 37.5 mg |
RISPERIDONE |
2103233399 |
4400436, 4401177, 4401795 |
|
|
Ryxidal 50 mg |
RISPERIDONE |
2103233398 |
4400437, 4401796, 4401797 |
|
|
Syngro 20 mg |
OCTREOTIDE ACETATE |
3010222847 |
4500329, 4401323 |
|
|
Syngro 30 mg |
OCTREOTIDE ACETATE |
3010222848 |
4500285 |
Issue :
The SFDA has issued a recall for products manufactured by PHARMATHEN INTERNATIONAL due to non-compliance with the approved specifications, following the company’s decision to withdraw the products from the local market.
Recommendations :
For healthcare professionals: Stop dispensing the above batches immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).